GDTC
CytoMed Therapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · SG
$0.85
−3.17%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.62x
- Price / sales
- 18.07x
- Price / cash flow
- -2.33x
Enterprise value
- Enterprise value
- $9.7M
- EV / sales
- 17.27x
- EV / EBITDA
- -2.12x
- EV / EBIT
- -2.23x
- Market cap
- $10.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026